Literature DB >> 18398912

A case of parkinsonism worsened by losartan: a probable new adverse effect.

G R K Sarma1, Vikram Kamath1, Thomas Mathew1, A K Roy1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398912     DOI: 10.1002/mds.21945

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  5 in total

1.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 2.  Arterial hypertension, a tricky side of Parkinson's disease: physiopathology and therapeutic features.

Authors:  Alberto Mazza; Roberta Ravenni; Angelo Antonini; Edoardo Casiglia; Domenico Rubello; Paolo Pauletto
Journal:  Neurol Sci       Date:  2012-11-30       Impact factor: 3.307

3.  Importance of the brain Angiotensin system in Parkinson's disease.

Authors:  John W Wright; Joseph W Harding
Journal:  Parkinsons Dis       Date:  2012-11-07

Review 4.  A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.

Authors:  John W Wright; Leen H Kawas; Joseph W Harding
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-25       Impact factor: 5.555

5.  Side chain similarity comparisons for integrated drug repositioning and potential toxicity assessments in epidemic response scenarios: The case for COVID-19.

Authors:  Nur Syatila Ab Ghani; Reeki Emrizal; Haslina Makmur; Mohd Firdaus-Raih
Journal:  Comput Struct Biotechnol J       Date:  2020-10-21       Impact factor: 7.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.